India to Gain Faster, Affordable Access to CAR T Therapy as NKure Therapeutics Partners with CRISPR Therapeutics
Strategic collaboration to co-develop CTX112™ aims to address India’s growing burden of B-cell lymphomas with an off-the-shelf, CRISPR-engineered cell therapy offering scalable production and reduced treatment delays.